These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 949182

  • 1. Activity of cefamandole and other cephalosporins against aerobic and anaerobic bacteria.
    Ernst EC, Berger S, Barza M, Jacobus NV, Tally FP.
    Antimicrob Agents Chemother; 1976 May; 9(5):852-5. PubMed ID: 949182
    [Abstract] [Full Text] [Related]

  • 2. Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.
    Eykyn S, Jenkins C, King A, Phillips I.
    Antimicrob Agents Chemother; 1973 Jun; 3(6):657-61. PubMed ID: 4790616
    [Abstract] [Full Text] [Related]

  • 3. The in vitro spectrum of the cephalosporins.
    Washington JA.
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.
    Chow AW, Bednorz D.
    Antimicrob Agents Chemother; 1978 Nov; 14(5):668-71. PubMed ID: 727759
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of LY127935.
    Fass RJ.
    Antimicrob Agents Chemother; 1979 Oct; 16(4):503-9. PubMed ID: 518080
    [Abstract] [Full Text] [Related]

  • 6. Anaerobic bacteria: evaluation of disc susceptibility to four cephalosporins.
    Dubois J, Pechère JC.
    Infection; 1978 Oct; 6(6):266-70. PubMed ID: 730395
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP, Jacobus NV, Bartlett JG, Gorbach SL.
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [Abstract] [Full Text] [Related]

  • 8. Study of cefoperazone's in vitro antibacterial activity, in comparison with other cephalosporins, on 512 gram-negative bacterial strains.
    Dainelli B, Magni A, Maragoni F, Berlutti F, Thaller MC, Filadoro F.
    G Batteriol Virol Immunol; 1981 Feb; 74(1-6):8-14. PubMed ID: 6458528
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of cefaclor against aerobic and anaerobic bacteria.
    Bach VT, Khurana MM, Thadepalli H.
    Antimicrob Agents Chemother; 1978 Feb; 13(2):210-3. PubMed ID: 646343
    [Abstract] [Full Text] [Related]

  • 10. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II.
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.
    Eykyn S, Jenkins C, King A, Phillips I.
    Antimicrob Agents Chemother; 1976 Apr; 9(4):690-5. PubMed ID: 1267441
    [Abstract] [Full Text] [Related]

  • 12. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH, Opfer BJ, Gerding DN.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK, Carrizosa J, Levison ME.
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of cefcanel versus other oral cephalosporins.
    Chin NX, Gu JW, Neu HC.
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC, Ho SW.
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of anaerobic bacteria to 23 antimicrobial agents.
    Sutter VL, Finegold SM.
    Antimicrob Agents Chemother; 1976 Oct; 10(4):736-52. PubMed ID: 984809
    [Abstract] [Full Text] [Related]

  • 17. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.
    Neu HC, Aswapokee N, Aswapokee P, Fu KP.
    Antimicrob Agents Chemother; 1979 Feb; 15(2):273-81. PubMed ID: 426518
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L.
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [Abstract] [Full Text] [Related]

  • 19. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL, Schoenknect FD, Shadomy S, Sherris JC, Thornsberry C, Washington JA, Kammer RB.
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.
    Sosna JP, Murray PR, Medoff G.
    Antimicrob Agents Chemother; 1978 Dec; 14(6):876-9. PubMed ID: 742875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.